What is Stem Cell?
Stem cells are a set of undifferentiated cells that can differentiate into specialized cell types and the development of new cells. Mostly, stem cells do come from two sources: Embryos during the phase of embryological development (embryonic stem cells) and adult tissue (adult stem cells).
Uses of Stem Cells
Stem cells mainly include Embryonic stem cells, Pluripotent stem cells, Epiblast-derived stem cells, and Adult tissue stem cells.
Embryonic stem cells are pluripotent, thus, can differentiate into the endoderm, mesoderm, and ectoderm, as such, can potentially be used to replace or restore tissues that have been damaged by disease or injury, such as diabetes, heart attacks, Parkinson’s disease or spinal cord injury.
Umbilical cord stem cells transplants are less prone to immune systems incompatibilities, unlike either the peripheral blood or bone marrow stem cells, they are also mostly available, contained in the umbilical cord and placenta of a newborn child, which can be easily collected and stored (frozen) for later use. Due to availability and versatility, they are used significantly for transplant therapies.
Peripheral blood stem cells (found in the bloodstream) can be transplanted to replace blood-forming stem cells that have been destroyed by disease, or by the radiation or high doses of anticancer drugs.
Peripheral blood stem cells can also be used to treat blood cancer leukemia), other cancers, immune disorders, as well as used to treat some other blood and bone marrow related diseases.
What is Stem Cell Innovations all about?
Stem Cell Innovations is a project that focuses on research, as well as development and the implementation of stem cell science, with the main purposes of providing affordable and easy access to stem cell treatments through technology and therefore, increases the human lifespan.
Stem Cell Innovations (SCI) is a network that consists of devoted researchers with insight, medical expert and professionals, dedicated investors, and innovative engineers who are working together to bring about an evolutionary platform that would make use two of the most significant inventions of the modern era to create a unique platform: stem cell technology and blockchain technology.
Stem Cell Innovations (SCI) was founded initially in early 2013 under name Camden RAD, LLC. SCI since then has played pivotal roles in research, development, and implementations involving stem cells technology around the world. Also, SCI had, however, conducted both domestic and international case studies for further researches about the stem cell science have directly contributed to advancements in the field, as well as new stem cell discoveries around the world.
Enhancements to be provided to the Stem Cell Technology by SCI
Stem Cell Innovations, together with its diverse and efficient network of professionals and world-class core team, aim to solve several problems in the stem cell industry today by providing:
Access to quality treatments for patients with a variety and complicated medical conditions.
Unlimited access to, and sharing of concise information related to stem cell technology and research.
Abstract communication between professional researchers and medical experts who could treat patients with effective stem cell therapies.
SCI is highly motivated to connect patients who need treatment with the right dedicated solutions and professionals for their unique or specific needs.
Devotion to international research, development, and implementation of stem cell therapy.
Expansion and provision of professionals, labs, clinics, hospitals, and nonprofit organizations around the world.
Stem Cell Innovation is working towards building a world where each and everyone, regardless of where they come from, will have easy access to a Stem Cell Specialist instantly through its Stem Cell Innovations application (SCI Application), and via the same SCI Application, could also decide when and how much of confidential informations to share with the specialist.
The Stem Cell Application
The SCI Application will enable users to access their individualized stem cell profile, which will facilitate access to stem cell therapies and services in a hassle-free and straightforward manner.
The SCI Application can also help people manage their health and wellness, promote healthy living, and gain access to the world of stem cell innovations. Often, such tools are adopted almost as soon as they get developed, and according to the US Food and Drug Administration, “by 2018, 50% of the more than 3.4 billion smartphone and tablet users will have downloaded mobile health applications.
Stem Cell Innovations Token Informations and Distribution.
The Stem Cell Innovations token will be implemented as an ERC-20 token over the Ethereum public blockchain. The token will primarily be used within the SCI ecosystem as a method for users to access the full range of SCI products and services. Given the self-contained nature of the ecosystem, a token-based model for product usage will support security and exclusivity of access for SCI Application token holders, which will, in turn, drive the fundamental value of the token.
SCI’s goal is to raise a maximum of $36,000,000 and a minimum of $3,000,000. Some of these numbers may change with ETH/ USD exchange rates and volatility throughout the ICO and launch phase of the company’s growth. This document is based on exchange rate estimates at the time of writing. SCI will mint a total of 800 million tokens. Of these, 240 million tokens will be available during the token sale to start on September 17, 2018. Each token will be sold at $0.15. Should all 240 million tokens be sold, the raised funds will be $36,000,000. Tokens unsold from the 240 million will be burned. The funds raised during the token sale are to be used per the project roadmap above. Pre-Sale from 17th September 2018 0800 HRS UTC/GMT to 29th October 2018 2359 HRS UTC/GMT. Main-Sale from 21st November 2018 0800 HRS UTC/GMT to 17th January 2019 2359 HRS UTC/GMT. The total number of tokens sold during the pre-sale period cannot exceed 60% of the total number of tokens initially put up for sale by the Main-Sale. If the number of requests received during the pre-sale period exceeds, request will be honored in the chronological order in line with the set limit, and excess orders will be returned to clients
Conclusions:
Stem Cell Technology idea is not new but, the Niche is wide open and, Implementation of such technology on another Modern Era Technology such as the Blockchain proves the focal point of the whole concept. The Stem Cell Innovations Ecosystem backed by Blockchain technology will indeed provide a real case use for SCIA Tokens as such render it highly valuable.
For further Informations:
Website: https://scia.io/
Facebook: https://www.facebook.com/Stemcellapp
Twitter: https://twitter.com/stemcellapp
Telegram: https://t.me/stemcellinnovations
Medium: https://medium.com/@stemcellapp
Author Details:
Bountyhive User: https://bountyhive.io/r/Oyebamijijr
